Image: Willy Barton, via Shutterstock.com
Medical academy aims to help researchers identify collaborations and share expertise and materials
The Academy of Medical Sciences has launched a database for tracking early-stage UK Covid-19 research.
Announced on 1 June, the Covid-19 preclinical drug development database aims to help researchers identify collaborations, share expertise, materials and methods, as well as prioritise research and avoid duplicating effort.
The academy is calling on researchers from across academia and industry to submit projects to the database through an optional survey.
“The sustained and long-term control of Covid-19 will require new anti-infectives,” said Michael Malim, chair of the project. “In launching our registry for preclinical drug development, the academy seeks to foster transparency, collaboration and policy development in this vital area of research.
“We hope this resource will be of broad importance, and we encourage scientists from industry and academy to freely contribute relevant work.”